NKTX
Price
$1.90
Change
+$0.07 (+3.83%)
Updated
Jun 6 closing price
Capitalization
129.85M
60 days until earnings call
RGLS
Price
$8.22
Change
+$0.12 (+1.48%)
Updated
Jun 6 closing price
Capitalization
560.8M
65 days until earnings call
Interact to see
Advertisement

NKTX vs RGLS

Header iconNKTX vs RGLS Comparison
Open Charts NKTX vs RGLSBanner chart's image
Nkarta
Price$1.90
Change+$0.07 (+3.83%)
Volume$615.35K
Capitalization129.85M
Regulus Therapeutics
Price$8.22
Change+$0.12 (+1.48%)
Volume$2.78M
Capitalization560.8M
NKTX vs RGLS Comparison Chart
Loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTX vs. RGLS commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTX is a Buy and RGLS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (NKTX: $1.76 vs. RGLS: $7.93)
Brand notoriety: NKTX and RGLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTX: 23% vs. RGLS: 29%
Market capitalization -- NKTX: $129.85M vs. RGLS: $560.8M
NKTX [@Biotechnology] is valued at $129.85M. RGLS’s [@Biotechnology] market capitalization is $560.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTX’s FA Score shows that 1 FA rating(s) are green whileRGLS’s FA Score has 0 green FA rating(s).

  • NKTX’s FA Score: 1 green, 4 red.
  • RGLS’s FA Score: 0 green, 5 red.
According to our system of comparison, RGLS is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTX’s TA Score shows that 3 TA indicator(s) are bullish while RGLS’s TA Score has 4 bullish TA indicator(s).

  • NKTX’s TA Score: 3 bullish, 6 bearish.
  • RGLS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RGLS is a better buy in the short-term than NKTX.

Price Growth

NKTX (@Biotechnology) experienced а +3.53% price change this week, while RGLS (@Biotechnology) price change was +0.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

NKTX is expected to report earnings on Aug 07, 2025.

RGLS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGLS($561M) has a higher market cap than NKTX($130M). RGLS YTD gains are higher at: 401.899 vs. NKTX (-29.317). RGLS has higher annual earnings (EBITDA): -45.85M vs. NKTX (-119.34M). NKTX has more cash in the bank: 283M vs. RGLS (75.8M). RGLS has less debt than NKTX: RGLS (274K) vs NKTX (85.4M). NKTX (0) and RGLS (0) have equivalent revenues.
NKTXRGLSNKTX / RGLS
Capitalization130M561M23%
EBITDA-119.34M-45.85M260%
Gain YTD-29.317401.899-7%
P/E RatioN/AN/A-
Revenue00-
Total Cash283M75.8M373%
Total Debt85.4M274K31,168%
FUNDAMENTALS RATINGS
RGLS: Fundamental Ratings
RGLS
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTXRGLS
RSI
ODDS (%)
Bearish Trend 12 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
78%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
89%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
85%
Advances
ODDS (%)
Bullish Trend about 1 month ago
85%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
86%
Bearish Trend 12 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+1.15%
BEAM - NKTX
49%
Loosely correlated
-0.88%
CRBU - NKTX
48%
Loosely correlated
+2.75%
KYMR - NKTX
48%
Loosely correlated
+2.35%
FATE - NKTX
47%
Loosely correlated
+4.10%
CCCC - NKTX
47%
Loosely correlated
-3.08%
More

RGLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGLS has been loosely correlated with ABEO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RGLS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGLS
1D Price
Change %
RGLS100%
+0.25%
ABEO - RGLS
43%
Loosely correlated
-2.12%
NKTX - RGLS
32%
Poorly correlated
+1.15%
NAUT - RGLS
31%
Poorly correlated
-3.95%
ATOS - RGLS
31%
Poorly correlated
-3.13%
XENE - RGLS
30%
Poorly correlated
-3.29%
More